Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Authors
Keywords
clinical trials, FDA, nanomedicine, nanoparticles, nanopharmaceuticals, nanotherpeutics
Journal
PHARMACEUTICAL RESEARCH
Volume 33, Issue 10, Pages 2373-2387
Publisher
Springer Nature
Online
2016-06-15
DOI
10.1007/s11095-016-1958-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Immunogenicity of long-lasting recombinant factor VIII products
- (2016) Mathieu Ing et al. CELLULAR IMMUNOLOGY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Long-term monitoring for nanomedicine implants and drugs
- (2016) Michaela Kendall et al. Nature Nanotechnology
- Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
- (2016) Susan Ashton et al. Science Translational Medicine
- Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
- (2015) Marina A. Dobrovolskaia JOURNAL OF CONTROLLED RELEASE
- Design considerations for nanotherapeutics in oncology
- (2015) Triantafyllos Stylianopoulos et al. Nanomedicine-Nanotechnology Biology and Medicine
- Silica–gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial
- (2015) Alexander N. Kharlamov et al. Nanoscale
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging
- (2015) Yi-Xiang J Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes Into Drugs, 2nd Edition
- (2014) D. M. Benbrook CLINICAL INFECTIOUS DISEASES
- Polymer therapeutics: Top 10 selling pharmaceuticals — What next?
- (2014) Ruth Duncan JOURNAL OF CONTROLLED RELEASE
- Emerging applications for ferumoxytol as a contrast agent in MRI
- (2014) Mustafa R. Bashir et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Multimodal Polymer Nanoparticles with Combined 19F Magnetic Resonance and Optical Detection for Tunable, Targeted, Multimodal Imaging in Vivo
- (2014) Barbara E. Rolfe et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Size-Dependent Effects of Gold Nanoparticles Uptake on Maturation and Antitumor Functions of Human Dendritic Cells In Vitro
- (2014) Sergej Tomić et al. PLoS One
- Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
- (2014) Julie Marill et al. Radiation Oncology
- Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
- (2014) E. Phillips et al. Science Translational Medicine
- What nanomedicine in the clinic right now really forms nanoparticles?
- (2014) Sonke Svenson Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections
- (2014) Mohamed Shehata Draz et al. Theranostics
- Emerging methods for the fabrication of polymer capsules
- (2013) Jiwei Cui et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Hyperthermia-induced drug targeting
- (2013) Jonathan P May et al. Expert Opinion on Drug Delivery
- Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
- (2013) Ahmad Awada et al. LANCET ONCOLOGY
- A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study
- (2013) Francine M. Foss et al. LEUKEMIA & LYMPHOMA
- Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
- (2013) Neil Senzer et al. MOLECULAR THERAPY
- Therapeutic nanoparticles in clinics and under clinical evaluation
- (2013) Catherine A Schütz et al. Nanomedicine
- Nanotheranostics for personalized medicine
- (2012) Simona Mura et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
- (2012) Fangqiong Tang et al. ADVANCED MATERIALS
- The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
- (2012) Alexandre Albanese et al. Annual Review of Biomedical Engineering
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
- (2012) Nazila Kamaly et al. CHEMICAL SOCIETY REVIEWS
- Design of polymeric nanoparticles for biomedical delivery applications
- (2012) Mahmoud Elsabahy et al. CHEMICAL SOCIETY REVIEWS
- Antibody–drug conjugates: Basic concepts, examples and future perspectives
- (2012) Giulio Casi et al. JOURNAL OF CONTROLLED RELEASE
- The big picture on nanomedicine: the state of investigational and approved nanomedicine products
- (2012) Michael L. Etheridge et al. Nanomedicine-Nanotechnology Biology and Medicine
- Plasmonic Photothermic and Stem Cell Therapy of Atherosclerotic Plaque As a Novel Nanotool for Angioplasty and Artery Remodeling
- (2012) Alexander N. Kharlamov et al. REJUVENATION RESEARCH
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Size dependence of Au NP-enhanced surface plasmon resonance based on differential phase measurement
- (2012) Shuwen Zeng et al. SENSORS AND ACTUATORS B-CHEMICAL
- Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis
- (2011) Stefan Tenzer et al. ACS Nano
- Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
- (2011) Rajib Ghosh Chaudhuri et al. CHEMICAL REVIEWS
- The golden age: gold nanoparticles for biomedicine
- (2011) Erik C. Dreaden et al. CHEMICAL SOCIETY REVIEWS
- A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
- (2011) Xiao Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
- (2011) Sonke Svenson et al. JOURNAL OF CONTROLLED RELEASE
- Toxicology and clinical potential of nanoparticles
- (2011) Lara Yildirimer et al. Nano Today
- In vivobiodistribution of nanoparticles
- (2011) Joao Paulo Mattos Almeida et al. Nanomedicine
- FDA-approved poly(ethylene glycol)–protein conjugate drugs
- (2011) Steevens N. S. Alconcel et al. Polymer Chemistry
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
- (2010) S. K. Libutti et al. CLINICAL CANCER RESEARCH
- Rexin-G, a targeted genetic medicine for cancer
- (2010) Erlinda M Gordon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives
- (2010) Ranjita Shegokar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
- (2010) Klaus Maier-Hauff et al. JOURNAL OF NEURO-ONCOLOGY
- Functional Hyperbranched Polymers: Toward Targetedin Vivo19F Magnetic Resonance Imaging Using Designed Macromolecules
- (2010) Kristofer J. Thurecht et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
- (2010) Chris Oerlemans et al. PHARMACEUTICAL RESEARCH
- Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture
- (2009) Megan E. Fox et al. ACCOUNTS OF CHEMICAL RESEARCH
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
- (2009) Sant P Chawla et al. MOLECULAR THERAPY
- Understanding biophysicochemical interactions at the nano–bio interface
- (2009) Andre E. Nel et al. NATURE MATERIALS
- Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
- (2008) L Paz-Ares et al. BRITISH JOURNAL OF CANCER
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- Clinical applications of magnetic nanoparticles for hyperthermia
- (2008) Burghard Thiesen et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Pharmacokinetics and Biodistribution of Nanoparticles
- (2008) Shyh-Dar Li et al. MOLECULAR PHARMACEUTICS
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now